Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Retained Earnings (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Retained Earnings for 16 consecutive years, with $184.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 3086.98% to $184.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $184.7 million, a 3086.98% increase, with the full-year FY2025 number at $184.7 million, up 3086.98% from a year prior.
  • Retained Earnings was $184.7 million for Q4 2025 at Lemaitre Vascular, up from -$2.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $184.7 million in Q4 2025 to a low of -$8.1 million in Q3 2022.
  • A 5-year average of $43.1 million and a median of -$3.0 million in 2025 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: tumbled 187.29% in 2022, then surged 3086.98% in 2025.
  • Lemaitre Vascular's Retained Earnings stood at $88.1 million in 2021, then grew by 10.95% to $97.8 million in 2022, then tumbled by 104.73% to -$4.6 million in 2023, then crashed by 33.71% to -$6.2 million in 2024, then soared by 3086.98% to $184.7 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Retained Earnings are $184.7 million (Q4 2025), -$2.9 million (Q3 2025), and -$3.0 million (Q2 2025).